Taevas
IndiaPharmaceuticals
Product Registration
Market Access for Product-Registration in India
Navigating the intricate global regulatory and commercial landscapes is critical for successful product launch. Taevas Life Sciences provides comprehensive market access strategies, ensuring your registered products achieve optimal patient reach and comme
Market
Global
Industry
Product-Registration
Regulator
Diverse National Regulatory Bodies
Timeline
6-12 weeks (initial strategy phase)
Deliverables
Market Access Strategy Report, HEOR Plan, Pricing Framework
What We Deliver
6 Pillars of Global Market Access for Registered Products
Every engagement covers a structured set of pillars — each customised to your specific category, target segment, and strategic questions.
01
Global Regulatory & Policy Intelligence
We provide in-depth analysis of the varied regulatory requirements and evolving policy landscapes across key global markets. This ensures your product registration strategy is inherently aligned with market access considerations from the outset.
Multi-national policy impact assessment
Horizon scanning for regulatory changes
How It Works
How Taevas Life Sciences Secures Your Global Market Access
A structured engagement — typically delivered in a few weeks.
Step 1 · Week 1-2
Discovery & Landscape Assessment
We initiate with a thorough analysis of your product's profile, target indications, and the specific global markets of interest. This includes a deep dive into regulatory status, competitive landscape, and payer environment.
Market Snapshot
Market Overview: Global Product-Registration & Access Dynamics
Increasing Payer Scrutiny
Global payers are increasingly demanding robust clinical and economic evidence, making strategic HEOR and value communication more critical than ever for product reimbursement.
Fragmented Global Landscape
The absence of a single global market access pathway necessitates country-specific strategies, requiring deep local expertise and adaptable approaches for successful product registration and launch.
Early Integration is Key
Integrating market access considerations early in the product development and registration process significantly improves the likelihood of optimal pricing and broad patient access upon launch.
What's Included
Deliverables
A structured, decision-ready package of deliverables.
Global Market Access Strategy Report
A comprehensive document outlining strategic pathways, key market insights, and recommended actions for each target market.
Health Economic & Outcomes Research Plan
A detailed plan for generating the necessary evidence to demonstrate clinical and economic value to global payers.
Value Dossier Framework & Content Support
Guidance and support for developing compelling global value dossiers tailored for regional and national submissions.
Pricing & Reimbursement Framework
A strategic framework for optimizing pricing and securing favorable reimbursement across diverse international markets.
Who This Is For
Use Cases
Biotech Launch
Launching a Novel Biologic in Multiple Regions
A biotech company with a newly registered biologic seeks to launch simultaneously in North America, Europe, and select APAC markets, requiring tailored market access strategies for each region.
Outcome
Achieved optimal pricing and reimbursement in all target markets within 12 months post-registration.
Next Steps
Related Services
FAQ
Frequently Asked Questions
Get Started
Ready to Start Market Access in Global?
Ensure your registered products achieve their full potential in the global marketplace. Partner with Taevas Life Sciences to develop and execute a winning market access strategy.
Accelerated time to market access
Optimized global pricing and reimbursement
Reduced commercialization risks
Maximized patient reach and product value